What's new

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 36, Status: Authorised

Mar 5, 2025 - 13:07
 0
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 36, Status: Authorised
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 36, Status: Authorised
Read More

Tags:

Previous Article

CHMP opinions on consultation procedures

Next Article

New North Sea tax would peg payments to oil and gas prices

Related Posts

Human medicines European public assessment report (EPAR): Viramune, nevirapine, Date of authorisation: 04/02/1998, Revision: 45, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation: 26/06/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0

Annex - National provisions for SMEs applicable to the ...

Feb 26, 2025  0